ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide.

Wassim Abida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.